Back
Corporate News
Camlin Fine Sciences to consider financial results and potential rights issue on Nov 3
29-Oct-2026, 07:01
Camlin Fine Sciences Limited will hold a board meeting on November 3, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, and a proposal for raising funds through a rights issue of equity shares or other securities, subject to required approvals. The company previously closed the trading window for its equity shares for designated persons and their immediate relatives from October 1, 2026, until November 5, 2026.